Literature DB >> 179841

Influence of cyclic nucleotides on protein synthesis in vascular smooth muscle.

R G Andersson, H J Arnqvist, L Lundholm.   

Abstract

The incorporation of leucine-14C into protein in bovine mesenteric arteries was augmented by cyclic GMP (10-3 M) and decreased by cyclic AMP (10-3 M). There was no effect of 5'AMP (10-3 M). The phosphodiesterase inhibiting drugs theophylline (10-3 M) and papaverine (5 x 10-5 g/ml) both decreased the leucine-14C incorporation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 179841     DOI: 10.1007/bf01990186

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  7 in total

1.  Effect of cyclic 3'-5' GMP on in vitro protein synthesis.

Authors:  P De Nayer
Journal:  Biochimie       Date:  1973       Impact factor: 4.079

2.  Cyclic AMP and calcium ions in mechanical and metabolic responses of smooth muscles; influence of some hormones and drugs.

Authors:  R G Andersson
Journal:  Acta Physiol Scand Suppl       Date:  1972

3.  Effect of cyclic AMP on growth and morphological differentiation of an established myogenic cell line.

Authors:  J P Wahrmann; R Winand; D Luzzati
Journal:  Nat New Biol       Date:  1973-09-26

4.  Action of insulin on vascular and intestinal smooth muscle. Effects on amino acid transport, protein synthesis and accumulation of glucose carbon.

Authors:  H J Arnqvist
Journal:  Acta Physiol Scand       Date:  1974-01

5.  Long-term effects of hypertension on the rat aortic wall and their relation to concurrent aging changes. Morphological and chemical studies.

Authors:  H Wolinsky
Journal:  Circ Res       Date:  1972-03       Impact factor: 17.367

6.  Dietary-induced atherosclerosis in miniature swine.

Authors:  R A Florentin; S C Nam; A S Daoud; R Jones; R F Scott; E S Morrison; D N Kim; K T Lee; W A Thomas; W J Dodds; K D Miller
Journal:  Exp Mol Pathol       Date:  1968-06       Impact factor: 3.362

7.  Cyclic adenosine monophosphate and hypertension in rats.

Authors:  M S Amer
Journal:  Science       Date:  1973-02-23       Impact factor: 47.728

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.